Orchid Chemicals gets CCI’s nod to sell assets to Hospira Healthcare

26 Dec 2012 Evaluate

Orchid Chemicals and Pharmaceuticals (OCPL) has received Competition Commission of India’s (CCI) approval for proposed sale of its certain assets to Hospira Healthcare.

According to the deal, OCPL has agreed to offload its Betaculum API (Active Pharmaceutical Ingredients) business along with its manufacturing facilities, as also another manufacturing facility in Aurangabad and an R&D facility in Chennai to Hospira Healthcare India (HHIPL), a 100% subsidiary of US-based Hospira Inc. However, the deal excludes certain oral formulation businesses of OCPL as also some API assets.

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

865.95 0.80 (0.09%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×